General Medicine and Primary Care

Guest: Audrey Bui, DO

Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss how genetic variants influence risks for certain conditions, how they may predict response to therapies like methotrexate, ustekinumab, and IL-17 inhibitors, and how integrating genetic markers into clinical care can enable more targeted, effective psoriasis management. Dr. Bui is a recent graduate from Lake Erie College of Osteopathic Medicine and an intern at the University of Central Florida prior to starting her dermatology residency at Hackensack Meridian Health Palisades Medical Center.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Jeff Brandes

By embedding evidence-based metrics directly into existing workflows, the partnership between the American Medical Association (AMA) and Azara Healthcare supports providers in proactively managing hypertension. To learn more about how integrating the AMA MAP™ Hypertension Quality Improvement Program into Azara’s population health tools empowers clinicians to seamlessly deliver guideline-driven care, Dr. Charles Turck speaks with Mr. Jeff Brandes, President and CEO of Azara Healthcare.

Guest: Meena B. Bansal, MD, FAASLD

Guest: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP

Guest: Fernando Bril, MD

The epidemic of metabolic dysfunction-associated liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) is fully upon the US healthcare system, and it's projected to get worse. The prevalence of MASLD in the US is expected to increase from 33.7% in 2020 to 41.4% in 2050, which translates to approximately 122 million adults being affected. Our broadcast on Global Fatty Liver Day provides practical and engaging discussions to help endocrinologists and primary care providers better understand the use of noninvasive tests and biomarkers for timely screening and primary risk assessment, treatment and management of cardiometabolic risk, and assignment to the appropriate level of care for patients with MASLD/MASH.

Guest: John Golden

Guest: Michael Greenberg, MD

EEG-guided headphones from Vital Neuro present a new frontier in anxiety management through personalized, real-time neurofeedback and music therapy. Dr. Michael Greenberg speaks with Vital Neuro CEO John Golden about the science behind these devices, their effectiveness in reducing anxiety symptoms, and how they can integrate into daily life.

Guest: John Golden

Host: Michael Greenberg, MD

Neuro-responsive EEG headphones are helping healthcare professionals combat burnout by promoting calm, focus, and resilience. Backed by neuroscience and real-time brain monitoring, this personalized technology blends music and neurofeedback to optimize mental states and reduce stress. Hear from Vital Neuro CEO John Golden as he joins Dr. Michael Greenberg to discuss this device's impact in clinical workflows, from pre-op anxiety management to enhanced physician well-being.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Michael Camilleri, MD

GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnesota, to discuss key findings on gastrointestinal side effects, procedural risks, and the impacts of GLP-1 receptor agonists on the fields of gastroenterology and hepatology.

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Guest: Faiyaz Syed MD, MPH

The Michigan Primary Care Association (MPCA) recently partnered with the AMA to implement the AMA MAP™ Hypertension Quality Improvement Program at two pilot health centers. After this collaboration resulted in a 6 percent improvement in hypertension control, it’s now expanding to all other MPCA health centers and could even focus on other conditions like diabetes. Joining Dr. Mary Katherine Cheeley to share his experience with the AMA MAP™ program is Dr. Faiyaz Syed, Chief Medical Officer for the MPCA.

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Guest: Rishi Wadhera, MD, MPP, Mphil

Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Guest: Rishi Wadhera, MD, MPP, Mphil

Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

Host: Rishi Wadhera, MD, MPP, Mphil

Guest: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.